Global Primary CD56+ NK Cells Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Primary CD56+ NK Cells market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Primary CD56+ Natural killer (NK) cells are the major effectors of the innate immune system and are important in host defense, cancer, and autoimmunity. CD56+ Natural Killer Cells are isolated from mononuclear cells by negative selection using immunomagnetic cell separation procedures.
This report is a detailed and comprehensive analysis for global Primary CD56+ NK Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Primary CD56+ NK Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Primary CD56+ NK Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Primary CD56+ NK Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PBM, ATCC, STEMCEITM, Thermo Fisher Scientific and AllCells, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Primary CD56+ NK Cells market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Primary CD56+ NK Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primary CD56+ NK Cells, with price, sales, revenue and global market share of Primary CD56+ NK Cells from 2018 to 2023.
Chapter 3, the Primary CD56+ NK Cells competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary CD56+ NK Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Primary CD56+ NK Cells market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primary CD56+ NK Cells.
Chapter 14 and 15, to describe Primary CD56+ NK Cells sales channel, distributors, customers, research findings and conclusion.
Primary CD56+ Natural killer (NK) cells are the major effectors of the innate immune system and are important in host defense, cancer, and autoimmunity. CD56+ Natural Killer Cells are isolated from mononuclear cells by negative selection using immunomagnetic cell separation procedures.
This report is a detailed and comprehensive analysis for global Primary CD56+ NK Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Primary CD56+ NK Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Primary CD56+ NK Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Primary CD56+ NK Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Primary CD56+ NK Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PBM, ATCC, STEMCEITM, Thermo Fisher Scientific and AllCells, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Primary CD56+ NK Cells market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Custom Made
- Bulk
- Compound Screening
- Immune Function Assay
- Drug Discovery
- Others
- PBM
- ATCC
- STEMCEITM
- Thermo Fisher Scientific
- AllCells
- ABM
- 3H Biomedical
- ProMab Biotechnologies
- AcceGen
- AMSBIO
- Clinisciences
- Creative Bioarray
- iCell Bioscience
- Shenzhen Kingfocus Biomedical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Primary CD56+ NK Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primary CD56+ NK Cells, with price, sales, revenue and global market share of Primary CD56+ NK Cells from 2018 to 2023.
Chapter 3, the Primary CD56+ NK Cells competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary CD56+ NK Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Primary CD56+ NK Cells market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primary CD56+ NK Cells.
Chapter 14 and 15, to describe Primary CD56+ NK Cells sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Primary CD56+ NK Cells
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Custom Made
1.3.3 Bulk
1.4 Market Analysis by Application
1.4.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Compound Screening
1.4.3 Immune Function Assay
1.4.4 Drug Discovery
1.4.5 Others
1.5 Global Primary CD56+ NK Cells Market Size & Forecast
1.5.1 Global Primary CD56+ NK Cells Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Primary CD56+ NK Cells Sales Quantity (2018-2029)
1.5.3 Global Primary CD56+ NK Cells Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 PBM
2.1.1 PBM Details
2.1.2 PBM Major Business
2.1.3 PBM Primary CD56+ NK Cells Product and Services
2.1.4 PBM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PBM Recent Developments/Updates
2.2 ATCC
2.2.1 ATCC Details
2.2.2 ATCC Major Business
2.2.3 ATCC Primary CD56+ NK Cells Product and Services
2.2.4 ATCC Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ATCC Recent Developments/Updates
2.3 STEMCEITM
2.3.1 STEMCEITM Details
2.3.2 STEMCEITM Major Business
2.3.3 STEMCEITM Primary CD56+ NK Cells Product and Services
2.3.4 STEMCEITM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 STEMCEITM Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
2.4.4 Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 AllCells
2.5.1 AllCells Details
2.5.2 AllCells Major Business
2.5.3 AllCells Primary CD56+ NK Cells Product and Services
2.5.4 AllCells Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AllCells Recent Developments/Updates
2.6 ABM
2.6.1 ABM Details
2.6.2 ABM Major Business
2.6.3 ABM Primary CD56+ NK Cells Product and Services
2.6.4 ABM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ABM Recent Developments/Updates
2.7 3H Biomedical
2.7.1 3H Biomedical Details
2.7.2 3H Biomedical Major Business
2.7.3 3H Biomedical Primary CD56+ NK Cells Product and Services
2.7.4 3H Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 3H Biomedical Recent Developments/Updates
2.8 ProMab Biotechnologies
2.8.1 ProMab Biotechnologies Details
2.8.2 ProMab Biotechnologies Major Business
2.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
2.8.4 ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ProMab Biotechnologies Recent Developments/Updates
2.9 AcceGen
2.9.1 AcceGen Details
2.9.2 AcceGen Major Business
2.9.3 AcceGen Primary CD56+ NK Cells Product and Services
2.9.4 AcceGen Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AcceGen Recent Developments/Updates
2.10 AMSBIO
2.10.1 AMSBIO Details
2.10.2 AMSBIO Major Business
2.10.3 AMSBIO Primary CD56+ NK Cells Product and Services
2.10.4 AMSBIO Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AMSBIO Recent Developments/Updates
2.11 Clinisciences
2.11.1 Clinisciences Details
2.11.2 Clinisciences Major Business
2.11.3 Clinisciences Primary CD56+ NK Cells Product and Services
2.11.4 Clinisciences Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Clinisciences Recent Developments/Updates
2.12 Creative Bioarray
2.12.1 Creative Bioarray Details
2.12.2 Creative Bioarray Major Business
2.12.3 Creative Bioarray Primary CD56+ NK Cells Product and Services
2.12.4 Creative Bioarray Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Creative Bioarray Recent Developments/Updates
2.13 iCell Bioscience
2.13.1 iCell Bioscience Details
2.13.2 iCell Bioscience Major Business
2.13.3 iCell Bioscience Primary CD56+ NK Cells Product and Services
2.13.4 iCell Bioscience Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 iCell Bioscience Recent Developments/Updates
2.14 Shenzhen Kingfocus Biomedical
2.14.1 Shenzhen Kingfocus Biomedical Details
2.14.2 Shenzhen Kingfocus Biomedical Major Business
2.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
2.14.4 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shenzhen Kingfocus Biomedical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRIMARY CD56+ NK CELLS BY MANUFACTURER
3.1 Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023)
3.2 Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023)
3.3 Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Primary CD56+ NK Cells by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.4.2 Top 6 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.5 Primary CD56+ NK Cells Market: Overall Company Footprint Analysis
3.5.1 Primary CD56+ NK Cells Market: Region Footprint
3.5.2 Primary CD56+ NK Cells Market: Company Product Type Footprint
3.5.3 Primary CD56+ NK Cells Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Primary CD56+ NK Cells Market Size by Region
4.1.1 Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
4.1.2 Global Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
4.1.3 Global Primary CD56+ NK Cells Average Price by Region (2018-2029)
4.2 North America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.3 Europe Primary CD56+ NK Cells Consumption Value (2018-2029)
4.4 Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029)
4.5 South America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.6 Middle East and Africa Primary CD56+ NK Cells Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
5.2 Global Primary CD56+ NK Cells Consumption Value by Type (2018-2029)
5.3 Global Primary CD56+ NK Cells Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
6.2 Global Primary CD56+ NK Cells Consumption Value by Application (2018-2029)
6.3 Global Primary CD56+ NK Cells Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
7.2 North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
7.3 North America Primary CD56+ NK Cells Market Size by Country
7.3.1 North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
7.3.2 North America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
8.2 Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
8.3 Europe Primary CD56+ NK Cells Market Size by Country
8.3.1 Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
8.3.2 Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Primary CD56+ NK Cells Market Size by Region
9.3.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
10.2 South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
10.3 South America Primary CD56+ NK Cells Market Size by Country
10.3.1 South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
10.3.2 South America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Primary CD56+ NK Cells Market Size by Country
11.3.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Primary CD56+ NK Cells Market Drivers
12.2 Primary CD56+ NK Cells Market Restraints
12.3 Primary CD56+ NK Cells Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Primary CD56+ NK Cells and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primary CD56+ NK Cells
13.3 Primary CD56+ NK Cells Production Process
13.4 Primary CD56+ NK Cells Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primary CD56+ NK Cells Typical Distributors
14.3 Primary CD56+ NK Cells Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Primary CD56+ NK Cells
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Custom Made
1.3.3 Bulk
1.4 Market Analysis by Application
1.4.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Compound Screening
1.4.3 Immune Function Assay
1.4.4 Drug Discovery
1.4.5 Others
1.5 Global Primary CD56+ NK Cells Market Size & Forecast
1.5.1 Global Primary CD56+ NK Cells Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Primary CD56+ NK Cells Sales Quantity (2018-2029)
1.5.3 Global Primary CD56+ NK Cells Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 PBM
2.1.1 PBM Details
2.1.2 PBM Major Business
2.1.3 PBM Primary CD56+ NK Cells Product and Services
2.1.4 PBM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PBM Recent Developments/Updates
2.2 ATCC
2.2.1 ATCC Details
2.2.2 ATCC Major Business
2.2.3 ATCC Primary CD56+ NK Cells Product and Services
2.2.4 ATCC Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ATCC Recent Developments/Updates
2.3 STEMCEITM
2.3.1 STEMCEITM Details
2.3.2 STEMCEITM Major Business
2.3.3 STEMCEITM Primary CD56+ NK Cells Product and Services
2.3.4 STEMCEITM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 STEMCEITM Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
2.4.4 Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 AllCells
2.5.1 AllCells Details
2.5.2 AllCells Major Business
2.5.3 AllCells Primary CD56+ NK Cells Product and Services
2.5.4 AllCells Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AllCells Recent Developments/Updates
2.6 ABM
2.6.1 ABM Details
2.6.2 ABM Major Business
2.6.3 ABM Primary CD56+ NK Cells Product and Services
2.6.4 ABM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ABM Recent Developments/Updates
2.7 3H Biomedical
2.7.1 3H Biomedical Details
2.7.2 3H Biomedical Major Business
2.7.3 3H Biomedical Primary CD56+ NK Cells Product and Services
2.7.4 3H Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 3H Biomedical Recent Developments/Updates
2.8 ProMab Biotechnologies
2.8.1 ProMab Biotechnologies Details
2.8.2 ProMab Biotechnologies Major Business
2.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
2.8.4 ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ProMab Biotechnologies Recent Developments/Updates
2.9 AcceGen
2.9.1 AcceGen Details
2.9.2 AcceGen Major Business
2.9.3 AcceGen Primary CD56+ NK Cells Product and Services
2.9.4 AcceGen Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AcceGen Recent Developments/Updates
2.10 AMSBIO
2.10.1 AMSBIO Details
2.10.2 AMSBIO Major Business
2.10.3 AMSBIO Primary CD56+ NK Cells Product and Services
2.10.4 AMSBIO Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AMSBIO Recent Developments/Updates
2.11 Clinisciences
2.11.1 Clinisciences Details
2.11.2 Clinisciences Major Business
2.11.3 Clinisciences Primary CD56+ NK Cells Product and Services
2.11.4 Clinisciences Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Clinisciences Recent Developments/Updates
2.12 Creative Bioarray
2.12.1 Creative Bioarray Details
2.12.2 Creative Bioarray Major Business
2.12.3 Creative Bioarray Primary CD56+ NK Cells Product and Services
2.12.4 Creative Bioarray Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Creative Bioarray Recent Developments/Updates
2.13 iCell Bioscience
2.13.1 iCell Bioscience Details
2.13.2 iCell Bioscience Major Business
2.13.3 iCell Bioscience Primary CD56+ NK Cells Product and Services
2.13.4 iCell Bioscience Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 iCell Bioscience Recent Developments/Updates
2.14 Shenzhen Kingfocus Biomedical
2.14.1 Shenzhen Kingfocus Biomedical Details
2.14.2 Shenzhen Kingfocus Biomedical Major Business
2.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
2.14.4 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shenzhen Kingfocus Biomedical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRIMARY CD56+ NK CELLS BY MANUFACTURER
3.1 Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023)
3.2 Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023)
3.3 Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Primary CD56+ NK Cells by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.4.2 Top 6 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.5 Primary CD56+ NK Cells Market: Overall Company Footprint Analysis
3.5.1 Primary CD56+ NK Cells Market: Region Footprint
3.5.2 Primary CD56+ NK Cells Market: Company Product Type Footprint
3.5.3 Primary CD56+ NK Cells Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Primary CD56+ NK Cells Market Size by Region
4.1.1 Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
4.1.2 Global Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
4.1.3 Global Primary CD56+ NK Cells Average Price by Region (2018-2029)
4.2 North America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.3 Europe Primary CD56+ NK Cells Consumption Value (2018-2029)
4.4 Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029)
4.5 South America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.6 Middle East and Africa Primary CD56+ NK Cells Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
5.2 Global Primary CD56+ NK Cells Consumption Value by Type (2018-2029)
5.3 Global Primary CD56+ NK Cells Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
6.2 Global Primary CD56+ NK Cells Consumption Value by Application (2018-2029)
6.3 Global Primary CD56+ NK Cells Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
7.2 North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
7.3 North America Primary CD56+ NK Cells Market Size by Country
7.3.1 North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
7.3.2 North America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
8.2 Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
8.3 Europe Primary CD56+ NK Cells Market Size by Country
8.3.1 Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
8.3.2 Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Primary CD56+ NK Cells Market Size by Region
9.3.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
10.2 South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
10.3 South America Primary CD56+ NK Cells Market Size by Country
10.3.1 South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
10.3.2 South America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Primary CD56+ NK Cells Market Size by Country
11.3.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Primary CD56+ NK Cells Market Drivers
12.2 Primary CD56+ NK Cells Market Restraints
12.3 Primary CD56+ NK Cells Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Primary CD56+ NK Cells and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primary CD56+ NK Cells
13.3 Primary CD56+ NK Cells Production Process
13.4 Primary CD56+ NK Cells Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primary CD56+ NK Cells Typical Distributors
14.3 Primary CD56+ NK Cells Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. PBM Basic Information, Manufacturing Base and Competitors
Table 4. PBM Major Business
Table 5. PBM Primary CD56+ NK Cells Product and Services
Table 6. PBM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. PBM Recent Developments/Updates
Table 8. ATCC Basic Information, Manufacturing Base and Competitors
Table 9. ATCC Major Business
Table 10. ATCC Primary CD56+ NK Cells Product and Services
Table 11. ATCC Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ATCC Recent Developments/Updates
Table 13. STEMCEITM Basic Information, Manufacturing Base and Competitors
Table 14. STEMCEITM Major Business
Table 15. STEMCEITM Primary CD56+ NK Cells Product and Services
Table 16. STEMCEITM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. STEMCEITM Recent Developments/Updates
Table 18. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
Table 21. Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Thermo Fisher Scientific Recent Developments/Updates
Table 23. AllCells Basic Information, Manufacturing Base and Competitors
Table 24. AllCells Major Business
Table 25. AllCells Primary CD56+ NK Cells Product and Services
Table 26. AllCells Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AllCells Recent Developments/Updates
Table 28. ABM Basic Information, Manufacturing Base and Competitors
Table 29. ABM Major Business
Table 30. ABM Primary CD56+ NK Cells Product and Services
Table 31. ABM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. ABM Recent Developments/Updates
Table 33. 3H Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. 3H Biomedical Major Business
Table 35. 3H Biomedical Primary CD56+ NK Cells Product and Services
Table 36. 3H Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. 3H Biomedical Recent Developments/Updates
Table 38. ProMab Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 39. ProMab Biotechnologies Major Business
Table 40. ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
Table 41. ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. ProMab Biotechnologies Recent Developments/Updates
Table 43. AcceGen Basic Information, Manufacturing Base and Competitors
Table 44. AcceGen Major Business
Table 45. AcceGen Primary CD56+ NK Cells Product and Services
Table 46. AcceGen Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AcceGen Recent Developments/Updates
Table 48. AMSBIO Basic Information, Manufacturing Base and Competitors
Table 49. AMSBIO Major Business
Table 50. AMSBIO Primary CD56+ NK Cells Product and Services
Table 51. AMSBIO Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AMSBIO Recent Developments/Updates
Table 53. Clinisciences Basic Information, Manufacturing Base and Competitors
Table 54. Clinisciences Major Business
Table 55. Clinisciences Primary CD56+ NK Cells Product and Services
Table 56. Clinisciences Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Clinisciences Recent Developments/Updates
Table 58. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 59. Creative Bioarray Major Business
Table 60. Creative Bioarray Primary CD56+ NK Cells Product and Services
Table 61. Creative Bioarray Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Creative Bioarray Recent Developments/Updates
Table 63. iCell Bioscience Basic Information, Manufacturing Base and Competitors
Table 64. iCell Bioscience Major Business
Table 65. iCell Bioscience Primary CD56+ NK Cells Product and Services
Table 66. iCell Bioscience Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. iCell Bioscience Recent Developments/Updates
Table 68. Shenzhen Kingfocus Biomedical Basic Information, Manufacturing Base and Competitors
Table 69. Shenzhen Kingfocus Biomedical Major Business
Table 70. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
Table 71. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shenzhen Kingfocus Biomedical Recent Developments/Updates
Table 73. Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Primary CD56+ NK Cells, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 78. Primary CD56+ NK Cells Market: Company Product Type Footprint
Table 79. Primary CD56+ NK Cells Market: Company Product Application Footprint
Table 80. Primary CD56+ NK Cells New Market Entrants and Barriers to Market Entry
Table 81. Primary CD56+ NK Cells Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Primary CD56+ NK Cells Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Primary CD56+ NK Cells Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Primary CD56+ NK Cells Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Primary CD56+ NK Cells Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Primary CD56+ NK Cells Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Primary CD56+ NK Cells Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Primary CD56+ NK Cells Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Primary CD56+ NK Cells Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Primary CD56+ NK Cells Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Primary CD56+ NK Cells Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Primary CD56+ NK Cells Raw Material
Table 141. Key Manufacturers of Primary CD56+ NK Cells Raw Materials
Table 142. Primary CD56+ NK Cells Typical Distributors
Table 143. Primary CD56+ NK Cells Typical Customers
Table 1. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. PBM Basic Information, Manufacturing Base and Competitors
Table 4. PBM Major Business
Table 5. PBM Primary CD56+ NK Cells Product and Services
Table 6. PBM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. PBM Recent Developments/Updates
Table 8. ATCC Basic Information, Manufacturing Base and Competitors
Table 9. ATCC Major Business
Table 10. ATCC Primary CD56+ NK Cells Product and Services
Table 11. ATCC Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ATCC Recent Developments/Updates
Table 13. STEMCEITM Basic Information, Manufacturing Base and Competitors
Table 14. STEMCEITM Major Business
Table 15. STEMCEITM Primary CD56+ NK Cells Product and Services
Table 16. STEMCEITM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. STEMCEITM Recent Developments/Updates
Table 18. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
Table 21. Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Thermo Fisher Scientific Recent Developments/Updates
Table 23. AllCells Basic Information, Manufacturing Base and Competitors
Table 24. AllCells Major Business
Table 25. AllCells Primary CD56+ NK Cells Product and Services
Table 26. AllCells Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AllCells Recent Developments/Updates
Table 28. ABM Basic Information, Manufacturing Base and Competitors
Table 29. ABM Major Business
Table 30. ABM Primary CD56+ NK Cells Product and Services
Table 31. ABM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. ABM Recent Developments/Updates
Table 33. 3H Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. 3H Biomedical Major Business
Table 35. 3H Biomedical Primary CD56+ NK Cells Product and Services
Table 36. 3H Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. 3H Biomedical Recent Developments/Updates
Table 38. ProMab Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 39. ProMab Biotechnologies Major Business
Table 40. ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
Table 41. ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. ProMab Biotechnologies Recent Developments/Updates
Table 43. AcceGen Basic Information, Manufacturing Base and Competitors
Table 44. AcceGen Major Business
Table 45. AcceGen Primary CD56+ NK Cells Product and Services
Table 46. AcceGen Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AcceGen Recent Developments/Updates
Table 48. AMSBIO Basic Information, Manufacturing Base and Competitors
Table 49. AMSBIO Major Business
Table 50. AMSBIO Primary CD56+ NK Cells Product and Services
Table 51. AMSBIO Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AMSBIO Recent Developments/Updates
Table 53. Clinisciences Basic Information, Manufacturing Base and Competitors
Table 54. Clinisciences Major Business
Table 55. Clinisciences Primary CD56+ NK Cells Product and Services
Table 56. Clinisciences Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Clinisciences Recent Developments/Updates
Table 58. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 59. Creative Bioarray Major Business
Table 60. Creative Bioarray Primary CD56+ NK Cells Product and Services
Table 61. Creative Bioarray Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Creative Bioarray Recent Developments/Updates
Table 63. iCell Bioscience Basic Information, Manufacturing Base and Competitors
Table 64. iCell Bioscience Major Business
Table 65. iCell Bioscience Primary CD56+ NK Cells Product and Services
Table 66. iCell Bioscience Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. iCell Bioscience Recent Developments/Updates
Table 68. Shenzhen Kingfocus Biomedical Basic Information, Manufacturing Base and Competitors
Table 69. Shenzhen Kingfocus Biomedical Major Business
Table 70. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
Table 71. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shenzhen Kingfocus Biomedical Recent Developments/Updates
Table 73. Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Primary CD56+ NK Cells, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 78. Primary CD56+ NK Cells Market: Company Product Type Footprint
Table 79. Primary CD56+ NK Cells Market: Company Product Application Footprint
Table 80. Primary CD56+ NK Cells New Market Entrants and Barriers to Market Entry
Table 81. Primary CD56+ NK Cells Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Primary CD56+ NK Cells Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Primary CD56+ NK Cells Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Primary CD56+ NK Cells Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Primary CD56+ NK Cells Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Primary CD56+ NK Cells Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Primary CD56+ NK Cells Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Primary CD56+ NK Cells Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Primary CD56+ NK Cells Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Primary CD56+ NK Cells Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Primary CD56+ NK Cells Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Primary CD56+ NK Cells Raw Material
Table 141. Key Manufacturers of Primary CD56+ NK Cells Raw Materials
Table 142. Primary CD56+ NK Cells Typical Distributors
Table 143. Primary CD56+ NK Cells Typical Customers
LIST OF FIGURES
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Primary CD56+ NK Cells Consumption Value Market Share by Type in 2022
Figure 4. Custom Made Examples
Figure 5. Bulk Examples
Figure 6. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Primary CD56+ NK Cells Consumption Value Market Share by Application in 2022
Figure 8. Compound Screening Examples
Figure 9. Immune Function Assay Examples
Figure 10. Drug Discovery Examples
Figure 11. Others Examples
Figure 12. Global Primary CD56+ NK Cells Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Primary CD56+ NK Cells Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Primary CD56+ NK Cells Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Primary CD56+ NK Cells Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Primary CD56+ NK Cells Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Primary CD56+ NK Cells Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Primary CD56+ NK Cells by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Primary CD56+ NK Cells Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Primary CD56+ NK Cells Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Primary CD56+ NK Cells Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Primary CD56+ NK Cells Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 54. China Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Primary CD56+ NK Cells Market Drivers
Figure 75. Primary CD56+ NK Cells Market Restraints
Figure 76. Primary CD56+ NK Cells Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Primary CD56+ NK Cells in 2022
Figure 79. Manufacturing Process Analysis of Primary CD56+ NK Cells
Figure 80. Primary CD56+ NK Cells Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Primary CD56+ NK Cells Consumption Value Market Share by Type in 2022
Figure 4. Custom Made Examples
Figure 5. Bulk Examples
Figure 6. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Primary CD56+ NK Cells Consumption Value Market Share by Application in 2022
Figure 8. Compound Screening Examples
Figure 9. Immune Function Assay Examples
Figure 10. Drug Discovery Examples
Figure 11. Others Examples
Figure 12. Global Primary CD56+ NK Cells Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Primary CD56+ NK Cells Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Primary CD56+ NK Cells Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Primary CD56+ NK Cells Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Primary CD56+ NK Cells Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Primary CD56+ NK Cells Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Primary CD56+ NK Cells by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Primary CD56+ NK Cells Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Primary CD56+ NK Cells Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Primary CD56+ NK Cells Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Primary CD56+ NK Cells Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 54. China Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Primary CD56+ NK Cells Market Drivers
Figure 75. Primary CD56+ NK Cells Market Restraints
Figure 76. Primary CD56+ NK Cells Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Primary CD56+ NK Cells in 2022
Figure 79. Manufacturing Process Analysis of Primary CD56+ NK Cells
Figure 80. Primary CD56+ NK Cells Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
